ZOSANO PHARMA CORP (ZSANXXXX)
Institutional ownership reported to the SEC as of Q2 2022, across 15 quarters.
1
Reporting holders
$24.0K
Reported value
0.0%
Held as options
-25
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Aisling Capital Management LP | $24.0K | 77,663 | 0.02% | 15q | -97.1%-$816.0K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2022 | 1 | $24.0K | 77,663 | 0 | 0 | 1 | 0.0% |
| Q1 2022 | 26 | $2.7M | 11,928,846 | 4 | 7 | 2 | 0.0% |
| Q4 2021 | 31 | $5.8M | 12,240,023 | 5 | 5 | 6 | 0.0% |
| Q3 2021 | 29 | $9.0M | 12,466,719 | 2 | 7 | 7 | 0.0% |
| Q2 2021 | 30 | $13.0M | 13,708,253 | 5 | 9 | 5 | 0.0% |
| Q1 2021 | 34 | $13.7M | 11,088,997 | 10 | 9 | 7 | 0.0% |
| Q4 2020 | 31 | $5.8M | 10,914,808 | 5 | 7 | 8 | 0.0% |
| Q3 2020 | 41 | $23.1M | 14,230,473 | 18 | 12 | 1 | 0.0% |
| Q2 2020 | 27 | $5.9M | 6,908,018 | 8 | 5 | 4 | 0.0% |
| Q1 2020 | 25 | $5.2M | 9,272,213 | 7 | 8 | 2 | 0.0% |
| Q4 2019 | 27 | $10.7M | 7,023,611 | 6 | 5 | 4 | 0.0% |
| Q3 2019 | 21 | $9.2M | 5,928,477 | 7 | 1 | 3 | 0.0% |
| Q2 2019 | 18 | $19.3M | 5,913,671 | 5 | 7 | 1 | 0.0% |
| Q1 2019 | 16 | $19.7M | 4,123,869 | 4 | 5 | 2 | 0.0% |
| Q4 2018 | 21 | $10.8M | 5,100,263 | 2 | 0 | 0 | 0.0% |